| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018725A1 2-substituted ketoamides |
| 04/06/2000 | WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 04/06/2000 | WO2000018723A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO1999067192A3 PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDE, KETONE, OXIME, AMINE, HYDROXAMIC ACID AND α,β-UNSATURATED CARBOXYLIC ACID AND ALDEHYDE COMPOUNDS |
| 04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | CA2345108A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/05/2000 | EP0989973A1 Chalcones having antiproliferative activity |
| 04/05/2000 | EP0989971A1 Glyoxylic acid amides |
| 04/05/2000 | EP0842137B1 A process for the preparation of cyclopropane carboxylic acids and intermediates therefor |
| 04/05/2000 | EP0814905B1 IMPROVED Ru, Re/CARBON CATALYST FOR HYDROGENATION IN AQUEOUS SOLUTION |
| 04/05/2000 | EP0785923B1 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/05/2000 | EP0740791A4 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties |
| 04/05/2000 | CN1249756A Metallocenes and catalysts for olefin-polymerisation |
| 04/05/2000 | CN1249290A Process for refining high-purity reagent by raction extractive reactification |
| 04/04/2000 | US6046281 Method for coupling living cationic polymers |
| 04/04/2000 | US6045662 Purifying cyclopropyl methyl ketone containing 4,5-dihydro-2-methylfuran or addition products as an impurity by rectifying the portion at a bottom temperature less than or equal to 160 degree c. to distill off the impurity |
| 04/04/2000 | CA2009850C Polymerisation of maleic anhydride |
| 03/30/2000 | WO2000017181A1 Method for producing tetrahydrofuran |
| 03/30/2000 | WO2000017176A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 03/30/2000 | WO2000017159A1 Arylsulfonanilide ureas |
| 03/30/2000 | WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/30/2000 | WO2000000483A9 Tubulin binding compounds (cobra) |
| 03/30/2000 | CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/29/2000 | EP0989125A1 Pesticidal furylmethyl cyclopropanecarboxylates |
| 03/29/2000 | EP0989114A1 N,n-disubstituted amic acid derivatives |
| 03/29/2000 | EP0988304A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 03/29/2000 | EP0988292A2 Piperazine derivatives and their use as anti-inflammatory agents |
| 03/29/2000 | EP0988289A2 Heterocyclic compounds, their production and use |
| 03/29/2000 | EP0988287A1 Method for producing nitroguanidine derivatives |
| 03/29/2000 | EP0859949A4 Process for extracting compounds from sample matrices |
| 03/29/2000 | CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor |
| 03/29/2000 | CN1248929A Method for producing acid phthalic and an appropriate shell catalyst containing |
| 03/29/2000 | CN1050838C Preparation process for lactone of IR, cis 2,2-dimethyl-3-formyl-cyclopropane-1-carboxylic acid and halogenated intermediates |
| 03/29/2000 | CN1050837C Continuous process for the manufacture of 2,5-dihydrofurans from gamma, delta-epoxybutenes |
| 03/28/2000 | US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 03/28/2000 | US6043381 Bind to retinoid receptors and primarily have retinoid antagonist or retinoid inverse agonist-like biological activity |
| 03/28/2000 | US6043359 Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2]benzazepine |
| 03/28/2000 | US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes |
| 03/28/2000 | US6043279 Compounds used for in vivo modulation of lipid metabolism, skin-related processes, malignant cell development, premalignant lesions, programmed cell death |
| 03/28/2000 | US6043264 Benzene-condensed heterocyclic derivatives and their uses |
| 03/28/2000 | US6043257 Amidinoindoles, amidinoazoles, and analogs thereof |
| 03/28/2000 | US6043247 Modulators of molecules with phosphotyrosine recognition units |
| 03/28/2000 | US6042620 p-diaminobenzene derivative compounds and dye compositions containing same |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/28/2000 | CA2109625C 3,5,3'-triiodothyronine receptor ligands |
| 03/28/2000 | CA2056662C Naphthoic acid derivative |
| 03/23/2000 | WO2000015634A2 Hiv protease inhibitors |
| 03/23/2000 | WO2000015624A1 2-ethyl-2,3-dihydrobenzofuran-carboxylic acid ester derivative, preparation method and use for preparing efaroxan derivatives |
| 03/23/2000 | WO2000015623A1 Syntheses of 5,5'-diformyl-2-2'difuran and derivatives thereof |
| 03/23/2000 | WO2000015212A2 Antifungal activity of dicationic molecules |
| 03/23/2000 | WO2000015210A2 Use of mycophenol acid and its derivatives for the treatment of virus diseases |
| 03/23/2000 | DE19843489A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors, useful for treatment of ischemia and other circulation disorders, tumors, prostatic hypertrophy and diabetic complications |
| 03/23/2000 | DE19842847A1 Production of tetrahydrofuran, useful as solvent and intermediate for polytetramethylene glycol, involves reacting anhydrous mixture of butan-1,4-diol and other alcohol on acid catalyst |
| 03/23/2000 | CA2344445A1 Antifungal activity of dicationic molecules |
| 03/23/2000 | CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors |
| 03/23/2000 | CA2310102A1 Syntheses of 5,5'-diformyl-2,2'difuran and derivatives thereof |
| 03/22/2000 | EP0987235A1 Method for the conversion of arenes or alkenes with iodoalkenes, aryl iodides or arenediazonium salts |
| 03/22/2000 | EP0986555A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same |
| 03/22/2000 | EP0986551A1 Sulfonamide derivatives, their production and use |
| 03/22/2000 | EP0986545A1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity |
| 03/22/2000 | EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/22/2000 | EP0986382A1 Raf kinase inhibitors |
| 03/22/2000 | EP0986302A1 A method of treating cancer |
| 03/22/2000 | EP0824531B1 Method for preparing an optically pure benzofuran carboxylic acid and use thereof for preparing efaroxan |
| 03/22/2000 | CN1247855A Preparation and application of tanshinpolyphenolic salt |
| 03/22/2000 | CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides |
| 03/21/2000 | US6040463 Sordarin derivatives |
| 03/21/2000 | US6040460 High productivity process to produce maleic anhydride from n-butane |
| 03/21/2000 | US6040444 Process for preparing furan nitrone compounds |
| 03/16/2000 | WO2000014082A1 Diarylmethylidene furan derivatives as drugs with anti-inflammatory, analgesic and chemopreventive properties |
| 03/16/2000 | WO2000014081A1 Continuous process for the production of anhydrosugar alcohols |
| 03/16/2000 | WO2000014065A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 03/16/2000 | WO2000014033A1 The addition of oxygen nucleophiles to vinyl epoxides |
| 03/16/2000 | WO2000013793A1 Method for producing catalysts for synthesising maleic anhydride by means of gas phase oxidation |
| 03/16/2000 | WO2000013648A2 Method for the preparation of citalopram |
| 03/16/2000 | WO2000008014A8 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 03/16/2000 | WO1999030548B1 Method for the preparation of citalopram |
| 03/16/2000 | DE19841032A1 Verfahren zur Herstellung von Anhydrozuckeralkoholen A process for the production of anhydrosugar |
| 03/16/2000 | CA2342994A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 03/16/2000 | CA2340348A1 Continuous process for the production of anhydrosugar alcohols |
| 03/15/2000 | EP0985669A1 PROCESS FOR PRODUCING CYCLOALKYL b]BENZOFURANS |
| 03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/15/2000 | EP0984954A1 Anti-mitotic agents which inhibit tubulin polymerization |
| 03/15/2000 | EP0984947A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 03/15/2000 | EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity |
| 03/15/2000 | EP0984914A1 Substituted 2-(3-alkenyl-benzoyl)-cyclohexane-1,3-diones |
| 03/15/2000 | EP0984778A1 Neuropeptide-y ligands |
| 03/15/2000 | CN1247530A Acrylonitrile compounds, process for their prodn. and pesticides containing them |
| 03/15/2000 | CN1247529A Sulfonamide and carboxamide derivatives and drugs containing same as active ingredient |
| 03/15/2000 | CN1050356C Process for preparing sodium (or potassium) L-ascorbate |
| 03/14/2000 | US6037498 Chiral syntheses |
| 03/14/2000 | US6037481 Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment |
| 03/14/2000 | US6037480 Process and compositions for the recovery of ascorbic acid |
| 03/14/2000 | US6037477 Oxidation process of ethers |
| 03/14/2000 | US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis |